{"id":"https://openalex.org/W2803486604","doi":"https://doi.org/10.1080/14756366.2018.1462801","title":"Structural re-positioning,in silicomolecular modelling, oxidative degradation, and biological screening of linagliptin as adenosine 3 receptor (ADORA3) modulators targeting hepatocellular carcinoma","display_name":"Structural re-positioning,in silicomolecular modelling, oxidative degradation, and biological screening of linagliptin as adenosine 3 receptor (ADORA3) modulators targeting hepatocellular carcinoma","publication_year":2018,"publication_date":"2018-01-01","ids":{"openalex":"https://openalex.org/W2803486604","doi":"https://doi.org/10.1080/14756366.2018.1462801","mag":"2803486604","pmid":"https://pubmed.ncbi.nlm.nih.gov/29768061","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/6010121"},"language":"en","primary_location":{"id":"doi:10.1080/14756366.2018.1462801","doi":"https://doi.org/10.1080/14756366.2018.1462801","is_oa":true,"landing_page_url":"https://doi.org/10.1080/14756366.2018.1462801","pdf_url":"https://www.tandfonline.com/doi/pdf/10.1080/14756366.2018.1462801?needAccess=true","source":{"id":"https://openalex.org/S192603849","display_name":"Journal of Enzyme Inhibition and Medicinal Chemistry","issn_l":"1475-6366","issn":["1475-6366","1475-6374"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Enzyme Inhibition and Medicinal Chemistry","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","datacite","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.tandfonline.com/doi/pdf/10.1080/14756366.2018.1462801?needAccess=true","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5113829263","display_name":"Bassam Mahfouz Ayoub","orcid":"https://orcid.org/0000-0002-3265-1567","observed_orcids":["https://orcid.org/0000-0002-3265-1567"]},"institutions":[{"id":"https://openalex.org/I154023281","display_name":"British University in Egypt","ror":"https://ror.org/0066fxv63","country_code":"EG","type":"education","lineage":["https://openalex.org/I154023281"]}],"countries":["EG"],"is_corresponding":false,"raw_author_name":"Bassam M. Ayoub","raw_affiliation_strings":["Pharmaceutical Chemistry Department, Faculty of Pharmacy, The British University in Egypt, El-Sherouk City, Egypt;","The Center for Drug Research and Development (CDRD), Faculty of Pharmacy, The British University in Egypt, El-Sherouk City, Egypt;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmaceutical Chemistry Department, Faculty of Pharmacy, The British University in Egypt, El-Sherouk City, Egypt;","institution_ids":["https://openalex.org/I154023281"]},{"raw_affiliation_string":"The Center for Drug Research and Development (CDRD), Faculty of Pharmacy, The British University in Egypt, El-Sherouk City, Egypt;","institution_ids":["https://openalex.org/I154023281"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082289067","display_name":"Yasmeen M. Attia","orcid":"https://orcid.org/0000-0003-4907-5209","observed_orcids":["https://orcid.org/0000-0003-4907-5209"]},"institutions":[{"id":"https://openalex.org/I154023281","display_name":"British University in Egypt","ror":"https://ror.org/0066fxv63","country_code":"EG","type":"education","lineage":["https://openalex.org/I154023281"]}],"countries":["EG"],"is_corresponding":false,"raw_author_name":"Yasmeen M. Attia","raw_affiliation_strings":["Pharmacology Department, Faculty of Pharmacy, The British University in Egypt, El-Sherouk City, Egypt","The Center for Drug Research and Development (CDRD), Faculty of Pharmacy, The British University in Egypt, El-Sherouk City, Egypt;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacology Department, Faculty of Pharmacy, The British University in Egypt, El-Sherouk City, Egypt","institution_ids":["https://openalex.org/I154023281"]},{"raw_affiliation_string":"The Center for Drug Research and Development (CDRD), Faculty of Pharmacy, The British University in Egypt, El-Sherouk City, Egypt;","institution_ids":["https://openalex.org/I154023281"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5101780663","display_name":"Mahmoud Salama Ahmed","orcid":"https://orcid.org/0000-0002-5600-4698","observed_orcids":["https://orcid.org/0000-0002-5600-4698"]},"institutions":[{"id":"https://openalex.org/I154023281","display_name":"British University in Egypt","ror":"https://ror.org/0066fxv63","country_code":"EG","type":"education","lineage":["https://openalex.org/I154023281"]}],"countries":["EG"],"is_corresponding":true,"raw_author_name":"Mahmoud S. Ahmed","raw_affiliation_strings":["Pharmaceutical Chemistry Department, Faculty of Pharmacy, The British University in Egypt, El-Sherouk City, Egypt;","The Center for Drug Research and Development (CDRD), Faculty of Pharmacy, The British University in Egypt, El-Sherouk City, Egypt;"],"raw_orcid":"https://orcid.org/0000-0002-5600-4698","affiliations":[{"raw_affiliation_string":"Pharmaceutical Chemistry Department, Faculty of Pharmacy, The British University in Egypt, El-Sherouk City, Egypt;","institution_ids":["https://openalex.org/I154023281"]},{"raw_affiliation_string":"The Center for Drug Research and Development (CDRD), Faculty of Pharmacy, The British University in Egypt, El-Sherouk City, Egypt;","institution_ids":["https://openalex.org/I154023281"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5101780663"],"corresponding_institution_ids":["https://openalex.org/I154023281"],"apc_list":{"value":1880,"currency":"GBP","value_usd":2306},"apc_paid":{"value":1880,"currency":"GBP","value_usd":2306},"fwci":1.365,"has_fulltext":false,"cited_by_count":17,"citation_normalized_percentile":{"value":0.75343456,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"33","issue":"1","first_page":"858","last_page":"866"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11193","display_name":"Adenosine and Purinergic Signaling","score":0.9878000020980835,"subfield":{"id":"https://openalex.org/subfields/1314","display_name":"Physiology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11193","display_name":"Adenosine and Purinergic Signaling","score":0.9878000020980835,"subfield":{"id":"https://openalex.org/subfields/1314","display_name":"Physiology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":0.00570000009611249,"subfield":{"id":"https://openalex.org/subfields/1703","display_name":"Computational Theory and Mathematics"},"field":{"id":"https://openalex.org/fields/17","display_name":"Computer Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.0008999999845400453,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/linagliptin","display_name":"linagliptin","score":1.0},{"id":"https://openalex.org/keywords/a3-adenosine-receptor","display_name":"A3 adenosine receptor","score":0.9129999876022339},{"id":"https://openalex.org/keywords/hepatocellular-carcinoma","display_name":"hepatocellular carcinoma","score":0.9169999957084656},{"id":"https://openalex.org/keywords/oxidative-degradation-products","display_name":"oxidative degradation products","score":0.8579999804496765},{"id":"https://openalex.org/keywords/dpp-4-inhibitors","display_name":"DPP-4 inhibitors","score":0.8889999985694885},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.49399998784065247},{"id":"https://openalex.org/keywords/g2-m-cell-cycle-arrest","display_name":"G2/M cell cycle arrest","score":0.8960000276565552},{"id":"https://openalex.org/keywords/caspase-3","display_name":"caspase-3","score":0.9940000176429749},{"id":"https://openalex.org/keywords/camp-signaling","display_name":"cAMP signaling","score":0.8629999756813049},{"id":"https://openalex.org/keywords/receptor-binding-affinity","display_name":"receptor binding affinity","score":0.6990000009536743},{"id":"https://openalex.org/keywords/pharmacophore-screening","display_name":"pharmacophore screening","score":0.7210000157356262},{"id":"https://openalex.org/keywords/structure-activity-relationship","display_name":"structure-activity relationship","score":0.5529999732971191}],"concepts":[{"id":"https://openalex.org/C2775905019","wikidata":"https://www.wikidata.org/wiki/Q192572","display_name":"In silico","level":3,"score":0.767076313495636},{"id":"https://openalex.org/C2780031085","wikidata":"https://www.wikidata.org/wiki/Q909745","display_name":"Linagliptin","level":4,"score":0.7378554940223694},{"id":"https://openalex.org/C56173144","wikidata":"https://www.wikidata.org/wiki/Q1539893","display_name":"Pharmacophore","level":2,"score":0.5878344774246216},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5389798879623413},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.5159812569618225},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.43784767389297485},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.4343907833099365},{"id":"https://openalex.org/C2776991684","wikidata":"https://www.wikidata.org/wiki/Q190012","display_name":"Adenosine","level":2,"score":0.41409388184547424},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.306252658367157},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.1762142777442932},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.07019513845443726},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.0},{"id":"https://openalex.org/C2910068830","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 Diabetes Mellitus","level":3,"score":0.0}],"mesh":[{"descriptor_ui":"D000069476","descriptor_name":"Linagliptin","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":false},{"descriptor_ui":"D000069476","descriptor_name":"Linagliptin","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000069476","descriptor_name":"Linagliptin","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D002453","descriptor_name":"Cell Cycle","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D003198","descriptor_name":"Computer Simulation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004354","descriptor_name":"Drug Screening Assays, Antitumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006528","descriptor_name":"Carcinoma, Hepatocellular","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D006528","descriptor_name":"Carcinoma, Hepatocellular","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D006528","descriptor_name":"Carcinoma, Hepatocellular","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008113","descriptor_name":"Liver Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D008113","descriptor_name":"Liver Neoplasms","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D008113","descriptor_name":"Liver Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D008958","descriptor_name":"Models, Molecular","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D010084","descriptor_name":"Oxidation-Reduction","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013329","descriptor_name":"Structure-Activity Relationship","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014407","descriptor_name":"Tumor Cells, Cultured","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015394","descriptor_name":"Molecular Structure","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017209","descriptor_name":"Apoptosis","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D043684","descriptor_name":"Receptor, Adenosine A3","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D043684","descriptor_name":"Receptor, Adenosine A3","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D049109","descriptor_name":"Cell Proliferation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false}],"locations_count":7,"locations":[{"id":"doi:10.1080/14756366.2018.1462801","doi":"https://doi.org/10.1080/14756366.2018.1462801","is_oa":true,"landing_page_url":"https://doi.org/10.1080/14756366.2018.1462801","pdf_url":"https://www.tandfonline.com/doi/pdf/10.1080/14756366.2018.1462801?needAccess=true","source":{"id":"https://openalex.org/S192603849","display_name":"Journal of Enzyme Inhibition and Medicinal Chemistry","issn_l":"1475-6366","issn":["1475-6366","1475-6374"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Enzyme Inhibition and Medicinal Chemistry","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:4992298","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/6010121","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:6010121","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/6010121","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"J Enzyme Inhib Med Chem","raw_type":"Text"},{"id":"pmid:29768061","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/29768061","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of enzyme inhibition and medicinal chemistry","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:d6b497e9605749ed903b95d3c34a8c37","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/d6b497e9605749ed903b95d3c34a8c37","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Journal of Enzyme Inhibition and Medicinal Chemistry, Vol 33, Iss 1, Pp 858-866 (2018)","raw_type":"article"},{"id":"pmh:oai:figshare.com:article/6278981","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/journal_contribution/Structural_re-positioning_i_in_silico_i_molecular_modelling_oxidative_degradation_and_biological_screening_of_linagliptin_as_adenosine_3_receptor_ADORA3_modulators_targeting_hepatocellular_carcinoma/6278981","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Text"},{"id":"doi:10.6084/m9.figshare.6278981.v1","doi":"https://doi.org/10.6084/m9.figshare.6278981.v1","is_oa":true,"landing_page_url":"https://doi.org/10.6084/m9.figshare.6278981.v1","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"article-journal"}],"best_oa_location":{"id":"doi:10.1080/14756366.2018.1462801","doi":"https://doi.org/10.1080/14756366.2018.1462801","is_oa":true,"landing_page_url":"https://doi.org/10.1080/14756366.2018.1462801","pdf_url":"https://www.tandfonline.com/doi/pdf/10.1080/14756366.2018.1462801?needAccess=true","source":{"id":"https://openalex.org/S192603849","display_name":"Journal of Enzyme Inhibition and Medicinal Chemistry","issn_l":"1475-6366","issn":["1475-6366","1475-6374"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Enzyme Inhibition and Medicinal Chemistry","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9537000060081482}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320330496","display_name":"British University in Egypt","ror":"https://ror.org/0066fxv63"}],"has_content":{"grobid_xml":false,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2803486604.pdf"},"referenced_works_count":36,"referenced_works":["https://openalex.org/W186512590","https://openalex.org/W1515416907","https://openalex.org/W1601888527","https://openalex.org/W1603274157","https://openalex.org/W1776221901","https://openalex.org/W1968361789","https://openalex.org/W1975391500","https://openalex.org/W1991485213","https://openalex.org/W2023743215","https://openalex.org/W2027729471","https://openalex.org/W2027844382","https://openalex.org/W2031760066","https://openalex.org/W2032037516","https://openalex.org/W2051809420","https://openalex.org/W2055802786","https://openalex.org/W2062383561","https://openalex.org/W2066169341","https://openalex.org/W2073642047","https://openalex.org/W2093777829","https://openalex.org/W2106861254","https://openalex.org/W2107277218","https://openalex.org/W2109501017","https://openalex.org/W2114360920","https://openalex.org/W2114918609","https://openalex.org/W2116238347","https://openalex.org/W2117349332","https://openalex.org/W2120151913","https://openalex.org/W2141857754","https://openalex.org/W2159073378","https://openalex.org/W2162543489","https://openalex.org/W2163352150","https://openalex.org/W2322666309","https://openalex.org/W2381737477","https://openalex.org/W2464458829","https://openalex.org/W2595202930","https://openalex.org/W2774315248"],"related_works":["https://openalex.org/W2787135601","https://openalex.org/W4386505406","https://openalex.org/W3193391334","https://openalex.org/W2113044908","https://openalex.org/W4406614059","https://openalex.org/W4385992063","https://openalex.org/W4392301389","https://openalex.org/W2895618002","https://openalex.org/W2333661782","https://openalex.org/W1995573045"],"abstract_inverted_index":{"Chemical":[0],"entities":[1],"with":[2,12,27,83,90,107],"structural":[3,63],"diversity":[4],"were":[5],"introduced":[6],"as":[7,40],"candidates":[8],"targeting":[9],"adenosine":[10,19],"receptor":[11],"different":[13],"clinical":[14],"activities,":[15],"containing":[16],"3,7-dihydro-1H-purine-2,6-dione,":[17],"especially":[18],"3":[20],"receptors":[21],"(ADORA3).":[22],"Our":[23],"initial":[24],"approach":[25],"started":[26],"pharmacophore":[28],"screening":[29],"of":[30,65,71,85,105,117,132,142],"ADORA3":[31,106,122,147],"modulators;":[32],"to":[33,44,126],"choose":[34],"linagliptin":[35],"(LIN),":[36],"approved":[37],"anti-diabetic":[38],"drug":[39],"Dipeptidyl":[41],"peptidase-4":[42],"inhibitors,":[43],"be":[45],"studied":[46],"for":[47],"its":[48],"modulating":[49],"effect":[50],"towards":[51,146],"ADORA3.":[52],"This":[53],"was":[54,123,148],"followed":[55],"by":[56,96],"generation,":[57],"purification,":[58],"analytical":[59],"method":[60],"development,":[61],"and":[62,73,101,144],"elucidation":[64],"oxidative":[66],"degraded":[67],"product":[68],"(DEG).":[69],"Both":[70],"LIN":[72,118,143],"DEG":[74,145],"showed":[75],"inhibitory":[76,128],"profile":[77,129],"against":[78,121],"hepatocellular":[79],"carcinoma":[80],"cell":[81],"lines":[82],"induction":[84],"apoptosis":[86],"at":[87,130],"G2/M":[88],"phase":[89],"increase":[91,110],"in":[92,99,111,114],"caspase-3":[93],"levels,":[94],"accompanied":[95],"a":[97,108],"downregulation":[98],"gene":[100],"protein":[102],"expression":[103],"levels":[104],"subsequent":[109],"cAMP.":[112],"Quantitative":[113],"vitro":[115],"assessment":[116],"binding":[119,140],"affinity":[120,141],"also":[124],"performed":[125],"exhibit":[127],"Ki":[131],"37.7":[133],"nM.":[134],"In":[135],"silico":[136],"molecular":[137],"modelling":[138],"showing":[139],"conducted.":[149]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":2},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2018-06-01T00:00:00"}